Skip to main content
Division of Cardiovascular Medicine Division of Cardiovascular Medicine
  1. HOME
  2. Programs
  3. General Clinical Cardiology
  4. Research

General Clinical Cardiology Research

  1. Editorial commentary: Type 2 MI and the sex divide: Moving from awareness to action
    Huang M, Phreaner N.
    Trends Cardiovasc Med. 2026 Jan;36(1):35-36. doi: 10.1016/j.tcm.2025.08.001. Epub 2025 Aug 5.

  2. The assessment and management of patients with type 2 myocardial infarction: an international Delphi study
    Taggart C, Ferry AV, Chapman AR, Schulberg SD, Bularga A, Wereski R, Boeddinghaus J, Kimenai DM, Lowry MTH, Chew DP, Cullen L, Daniels LB, Devereaux PJ, French J, Gaggin HK, Huynh T, Jacquin L, Jaffe AS, Jernberg T, Koronowski R, McCarthy C, McCord J, Mamas MA, Mickley H, Morrow DA, Mueller C, Newby LK, Parsonage W, Raphael CE, Smer A, Smith SW, Sandoval Y, Smilowitz NR, White H, Eggers KM, Lindahl B, Thygesen K, Mills NL.
    Eur Heart J Qual Care Clin Outcomes. 2025 Dec 19;11(8):1421-1430. doi: 10.1093/ehjqcco/qcaf069.

  3. Lipoprotein(a) Testing Trends in the United States 2015-2024: An Analysis of 300 Million Individuals
    Ramsis M, Naguib M, Dzotsi M, Wilkinson M, Mahmud E, Taub P, Bhatia HS.
    JACC Adv. 2025 Nov;4(11 Pt 1):102205. doi: 10.1016/j.jacadv.2025.102205. Epub 2025 Sep 23.

  4. Global lipoprotein (a) testing trends from 2015 to 2023
    Hanif M, Khan LA, Kulkarni A, Bhatia HS, Wilkinson MJ, Rashid AM, Chew NWS, Banerjee S, Butler J, Shapiro MD, Khan MS.
    Am Heart J. 2025 Nov;289:171-179. doi: 10.1016/j.ahj.2025.06.010. Epub 2025 Jun 21.

  5. First myocardial infarction: risk factors, symptoms, and medical therapy
    Nurmohamed NS, Ngo-Metzger Q, Taub PR, Ray KK, Figtree GA, Bonaca MP, Hsia JA, Angadageri S, Earls JP, Rodriguez F, Sandhu AT, Min JK, Hoffmann U, Maron DJ, Bhatt DL.
    Eur Heart J. 2025 Oct 7;46(38):3762-3772. doi: 10.1093/eurheartj/ehaf390.

  6. In-Hospital Mortality Risk Among Transfers to Cardiac Intensive Care Units
    Phreaner N, Villela MA, Bennett CE, Kenigsberg BB, Ding X, Durowoju RO, Fenerty A, Li B, Martillo Correa MA, Menon V, Nair RM, Newby LK, Oduah MT, Papolos AI, Morrow DA, Daniels LB.
    JACC Adv. 2025 Oct;4(10 Pt 1):102046. doi: 10.1016/j.jacadv.2025.102046. Epub 2025 Aug 20.

  7. Medical Intensive Care Unit Overflow Into the Cardiac Intensive Care Unit: Insights From CCCTN Registry
    Isath A, Bali A, Mahmood UA, Berg DD, Baird-Zars VM, Bohula EA, Daniels LB, Dodson M, Katz JN, Kwon Y, Loriaux D, Mukundan S, Newby LK, Park JG, Padkins M, Prasad R, Solomon MA, Zakaria S, Morrow DA, Cooper HA.
    JACC Adv. 2025 Oct;4(10 Pt 1):102048. doi: 10.1016/j.jacadv.2025.102048. Epub 2025 Aug 20.

  8. Disrupting the Status Quo: Reimagining How We Use Troponin for Diagnosing Myocardial Infarction
    Daniels LB, Peacock WF, Lindahl B, de Lemos JA.
    Circ Cardiovasc Qual Outcomes. 2025 Oct;18(10):e012131. doi: 10.1161/CIRCOUTCOMES.125.012131. Epub 2025 Aug 21.

  9. Peripheral arterial disease associated with elevated lipoprotein(a): a review of the evidence and treatment approaches
    Bhatia HS, Dalal S, Ross E.
    Curr Opin Lipidol. 2025 Oct 1;36(5):238-250. doi: 10.1097/MOL.0000000000000999. Epub 2025 Jun 13.

  10. Unsupervised Learning Analysis of Triglycerides, Inflammation, Cholesterol, and the Risks of Incident Cardiovascular Disease and Type 2 Diabetes in the Women's Health Study
    Duran EK, Cook NR, Aday AW, Buring JE, Ridker PM, Pradhan AD.
    J Am Heart Assoc. 2025 Sep 16;14(18):e039381. doi: 10.1161/JAHA.123.039381. Epub 2025 Sep 5.

  11. Human-Centered Design to Tailor Telehealth Cardiac Rehabilitation to Diverse Populations: The MCNAIR Study
    Oanesa RD, Atluri N, Boyd A, Khoury SR, Legeza V, Merritt JG, McNair P, Mishra SR, Ramsis M, Spaulding EM, Brewer LC, Forman DE, Golbus JR, Martin SS, Nallamothu BK, Beatty AL.
    J Am Heart Assoc. 2025 Sep 2;14(17):e040711. doi: 10.1161/JAHA.124.040711. Epub 2025 Aug 22.

  12. Identification and management of patients at high-risk for cardiovascular disease in primary prevention
    Ahlers M, John S, Bhatia H, Le V, Taub P.
    Am J Prev Cardiol. 2025 Aug 22;23:101265. doi: 10.1016/j.ajpc.2025.101265. eCollection 2025 Sep.

  13. Lipoprotein(a) at a "Tipping Point": case to move to universal screening
    Bhatia HS.
    Am J Prev Cardiol. 2025 Aug 22;23:101274. doi: 10.1016/j.ajpc.2025.101274. eCollection 2025 Sep.

  14. Elevated lipoprotein(a) in adverse pregnancy outcomes - Chicken or egg?
    Bhatia HS, Michos ED.
    Prog Cardiovasc Dis. 2025 Sep-Oct;92:180-181. doi: 10.1016/j.pcad.2025.09.001. Epub 2025 Sep 4.

  15. Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort
    Razavi AC, Chen J, Yang W, Sha D, Dzaye O, Bhatia HS, Tsimikas S, Lash JP, Kansal M, Rincon-Choles H, Vaccarino V, Jacobson TA, Budoff MJ, Blumenthal RS, Whelton SP, Sperling LS, Blaha MJ, He J; CRIC Study Investigators.
    JACC Adv. 2025 Sep;4(9):102068. doi: 10.1016/j.jacadv.2025.102068. Epub 2025 Aug 19.

  16. IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCE
    Cremer PC, Luis SA, Garshick MS, Raisinghani A, Weber B, Winnowski D, Clair J, Parameswaran V, Curtis A, Klein AL, Paolini JF; RESONANCE Study Group.
    JACC Adv. 2025 Sep;4(9):102050. doi: 10.1016/j.jacadv.2025.102050. Epub 2025 Aug 15.

  17. Pelacarsen: Mechanism of action and Lp(a)-lowering effect
    Bhatia HS, Bajaj A, Goonewardena SN, Moriarty PM.
    J Clin Lipidol. 2025 Sep-Oct;19(5):1208-1222. doi: 10.1016/j.jacl.2025.06.004. Epub 2025 Jun 16.

  18. Demographics of lipoprotein(a) and stroke: The UK biobank
    Kao AS, Kermanshahchi J, Khosrowjerdi S, Razavi AC, Levene J, Reyes M, Garg P, Longstreth WT Jr, Rannikmae K, Sudlow C, Tsai M, Tsimikas S, Saeed A, Bhatia HS.
    Am J Prev Cardiol. 2025 Jun 29;23:101055. doi: 10.1016/j.ajpc.2025.101055. eCollection 2025 Sep.

  19. Circulating protein biomarkers and their association with vulnerable plaque characteristics - a PROSPECT II substudy
    Sharma T, Maehara A, Maeng M, Kjøller-Hansen L, Engstrøm T, Ben-Yehuda O, Matsumura M, Fröbert O, Persson J, Wiseth R, Larsen AI, Koul S, Rylance R, Mintz GS, Ali ZA, James SK, Stone GW, Erlinge D.
    Int J Cardiol Cardiovasc Risk Prev. 2025 May 24;26:200440. doi: 10.1016/j.ijcrp.2025.200440. eCollection 2025 Sep.

  20. Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications
    Razavi AC, Bhatia HS, Blumenthal RS, Shapiro MD, Mehta A.
    Diabetes Obes Metab. 2025 Sep;27 Suppl 8(Suppl 8):34-46. doi: 10.1111/dom.16469. Epub 2025 May 28.

  21. First presentation of atherosclerotic cardiovascular disease in previously healthy individuals: The multi-ethnic study of atherosclerosis
    Kermanshahchi J, Kao AS, Ellberg CC, Duran E, Criqui MH, Shapiro MD, Bhatia HS.
    Prog Cardiovasc Dis. 2025 Sep-Oct;92:153-158. doi: 10.1016/j.pcad.2025.05.004. Epub 2025 May 14.

  22. High-sensitivity point-of-care measurement of cardiac troponin
    Cullen L, Mair J, Hammarsten O, Stengaard C, Boeddinghaus J, Daniels LB, Huber K, Giannitsis E, Jaffe AS, Kimenai DM, Krychtiuk KA, Lindahl B, Möckel M, Mueller C, Thielmann M, Thygesen K, Mills NL.
    Eur Heart J. 2025 Aug 7:ehaf407. doi: 10.1093/eurheartj/ehaf407. Online ahead of print.

  23. AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk : Insights From MESA and the UK Biobank
    Bhatia HS, Ambrosio M, Razavi AC, Alebna PL, Yeang C, Spitz JA, Patel J, Tsai MY, Sperling L, Shapiro MD, Tsimikas S, Mehta A.
    JAMA Cardiol. 2025 Aug 1;10(8):810-818. doi: 10.1001/jamacardio.2025.1603.

  24. Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD: The VICTORION-Mono Randomized Clinical Trial
    Taub PR, Gutierrez A, Wewers D, Garcia Cantu E, Cao H, Deck C, Lesogor A, Ott D, Mena-Madrazo J, Zang X, Wright RS.
    J Am Coll Cardiol. 2025 Jul 22;86(3):196-208. doi: 10.1016/j.jacc.2025.04.049. Epub 2025 May 5.

  25. Interpreting Elevated Lipoprotein(a) According to Baseline Atherosclerotic Cardiovascular Disease Risk
    Razavi AC, Whelton SP, Bhatia HS.
    Eur J Prev Cardiol. 2025 Jul 15:zwaf421. doi: 10.1093/eurjpc/zwaf421. Online ahead of print.

  26. Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian Individuals
    Patel D, Koschinsky ML, Agarwala A, Natarajan P, Bhatia HS, Mehta A, Patel J, Peters M, Pandya S, Sagheer U, Puri R, Virani SS, Kalra DK.
    J Am Heart Assoc. 2025 Jul 15;14(14):eJAHA2024040361T. doi: 10.1161/JAHA.124.040361. Epub 2025 Jul 14.

  27. From Epidemiology to Acute Coronary Syndromes: Risk Factors and Plaque Vulnerability
    Ben-Yehuda O.
    J Am Coll Cardiol. 2025 Jul 15;86(2):90-92. doi: 10.1016/j.jacc.2025.05.042.

  28. EJPC @ a Glance: Lipoprotein(a): new insights on an old enemy
    Bhatia HS, Aboyans V.
    Eur J Prev Cardiol. 2025 Jul 14;32(9):713-715. doi: 10.1093/eurjpc/zwaf312.

  29. Inconsistent association between lipoprotein(a) and coronary artery calcium
    Razavi AC, Blaha MJ, Bhatia HS.
    Eur J Prev Cardiol. 2025 Jul 14;32(9):756-757. doi: 10.1093/eurjpc/zwaf196.

  30. Traditional risk factors, optimal cardiovascular health, and elevated lipoprotein(a)
    Razavi AC, Reyes MP, Wilkins JT, Szklo MS, Tsai MY, Whelton SP, Sperling LS, Tsimikas S, Bhatia HS.
    Eur J Prev Cardiol. 2025 Jul 14;32(9):724-732. doi: 10.1093/eurjpc/zwae382.

  31. Family History of Premature Atherosclerotic Cardiovascular Disease and Lipoprotein(a) Levels: A Multi Cohort Analysis
    Razavi AC, Bhatia HS, Dardari ZA, Mehta A, Nasir K, Blankstein R, Isiadinso I, Quyyumi AA, Vaccarino V, Fialkow JA, Khoury MJ, Coronado F, Budoff MJ, Blumenthal RS, Whelton SP, Mortensen MB, Sperling LS, Matsushita K, Blaha MJ, Dzaye O.
    Eur J Prev Cardiol. 2025 Jul 8:zwaf392. doi: 10.1093/eurjpc/zwaf392. Online ahead of print.

  32. Anemia as a potent marker of in-hospital mortality in patients admitted to the cardiac intensive care unit: Data from the Critical Care Cardiology Trials Network (CCCTN) Registry
    Chow C, Durowoju R, Alviar C, Barsness GW, Cooper HA, Daniels LB, Ding X, Ghafghazi S, Gidwani U, Goldfarb M, Hillerson D, Katz JN, Marano P, Park JG, Pierce M, Rose SW, Roswell RO, van Diepen S, Wagle A, Bohula EA, Berg DD, Morrow DA, Kwon Y.
    J Intensive Med. 2025 Jan 24;5(3):262-268. doi: 10.1016/j.jointm.2024.12.006. eCollection 2025 Jul.

  33. Insights from a real-world experience with inclisiran at a large United States lipid clinic
    Mazdeyasnan D, Birs A, Chiou T, Diano L, Wilkinson MJ.
    J Clin Lipidol. 2025 Jul-Aug;19(4):812-818. doi: 10.1016/j.jacl.2025.06.015. Epub 2025 Jun 18.

  34. Implementation of a nonstatin prior authorization checklist for patients with hypercholesterolemia: In 2 community health care systems
    McCormick D, Taub PR, Carter J, Moreo K, Heggen CL.
    J Manag Care Spec Pharm. 2025 Jul;31(7):723-728. doi: 10.18553/jmcp.2025.31.7.723.

  35. Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review
    Cheeley MK, Kirkpatrick CF, Brown EE, Dixon DL, Gunter H, Osborn DS, Wilkinson MJ.
    J Clin Lipidol. 2025 Jul-Aug;19(4):737-747. doi: 10.1016/j.jacl.2025.05.002. Epub 2025 May 29.

  36. Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective-Brief Report
    Wilkinson MJ, Bijlani P, Davidson MH, Duell PB, Horan M, Malloy MJ, Newfield RS, Pradeep P, Shah PK, Stock EO, Warden BA, Ito MK.
    Arterioscler Thromb Vasc Biol. 2025 Jul;45(7):1310-1315. doi: 10.1161/ATVBAHA.124.322364. Epub 2025 May 29.

  37. JCL Roundtable: Dietary recommendations and intermittent fasting and time-restricted eating
    Maki KC, Kirkpatrick CF, Wilkinson MJ, Petersen KS.
    J Clin Lipidol. 2025 Jul-Aug;19(4):748-758. doi: 10.1016/j.jacl.2025.02.018. Epub 2025 Feb 27.

  38. Lp(a): Global Public Health Concern: Emerging Knowledge and Therapeutic Approaches
    Razavi AC, Hong J, Bhatia HS.
    Curr Cardiol Rep. 2025 Jun 25;27(1):104. doi: 10.1007/s11886-025-02255-2.

  39. Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS.
    Circulation. 2025 Jun 24;151(25):e1098. doi: 10.1161/CIR.0000000000001346. Epub 2025 Jun 23.

  40. Safety and Immediate Efficacy of Pulmonary Thromboendarterectomy for Chronic Thromboembolic Disease
    Bird EM, Yang JZ, Mims EW, Kerr KM, Papamatheakis DG, Poch DS, Fedullo PF, Malhotra A, Daniels LB, McDivit-Mizzell A, Phreaner N, Kim NH, Pretorius VG, Madani MM, Fernandes TM.
    Ann Thorac Surg. 2025 Jun 17:S0003-4975(25)00529-6. doi: 10.1016/j.athoracsur.2025.05.037. Online ahead of print.

  41. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS; Peer Review Committee Members.
    J Am Coll Cardiol. 2025 Jun 10;85(22):2135-2237. doi: 10.1016/j.jacc.2024.11.009. Epub 2025 Feb 27.

  42. TAVR for Asymptomatic Severe Aortic Stenosis
    Hoffman BU, Ben-Yehuda O.
    N Engl J Med. 2025 Jun 5;392(21):2176-2177. doi: 10.1056/NEJMc2502177.

  43. Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy
    Erlinge D, Tsimikas S, Maeng M, Maehara A, Larsen AI, Engstrøm T, Kjøller-Hansen L, Matsumura M, Ben-Yehuda O, Bøtker HE, Fröbert O, Persson J, Wiseth R, Jensen LO, Nordrehaug JE, Trovik T, Jensen U, Bleie Ø, Omerovic E, James SK, Rylance R, Sharma T, Ali ZA, Stone GW.
    J Am Coll Cardiol. 2025 Jun 3;85(21):2011-2024. doi: 10.1016/j.jacc.2025.04.013.

  44. Lipoprotein(a) and Atherosclerosis: Not So Little Anymore With Bigger Data
    Wong ND, Bhatia HS, Nasir K.
    J Am Coll Cardiol. 2025 Jun 3;85(21):1993-1995. doi: 10.1016/j.jacc.2025.03.504. Epub 2025 Apr 23.

  45. Disparities in statin use following identification of coronary artery calcium
    Ellberg CC, Bal K, Duran E, Criqui MH, Shapiro MD, Bhatia HS.
    Am J Prev Cardiol. 2025 Apr 11;22:100990. doi: 10.1016/j.ajpc.2025.100990. eCollection 2025 Jun.

  46. Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population
    Aggarwal R, Bhatt DL, Bonaca MP, Deck C, Lesogor A, Patel MR, Stroes ESG, Taub PR, Windecker S.
    Am J Prev Cardiol. 2025 Mar 8;22:100957. doi: 10.1016/j.ajpc.2025.100957. eCollection 2025 Jun.

  47. Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy
    Arslani K, Engstrøm T, Maeng M, Kjøller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Bøtker HE, Matsumura M, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Erlinge D, Stone GW.
    JACC Cardiovasc Imaging. 2025 Jun;18(6):696-706. doi: 10.1016/j.jcmg.2024.11.002. Epub 2025 Feb 24.

  48. Time-Restricted Eating Improves Quality of Life, Heart Rate, and Mitochondrial Function in Patients with Postural Orthostatic Tachycardia Syndrome
    Dzotsi M, Strohm A, Varshney S, Zuniga-Hertz JP, Chitteti R, Manoogian E, Sethi A, Panda S, Patel HH, Doherty TA, Taub P.
    medRxiv [Preprint]. 2025 May 31:2025.05.29.25328448. doi: 10.1101/2025.05.29.25328448.

  49. Prevalence and Correlates of Lipoprotein(a) Testing in a Diverse Cohort of U.S. Adults
    Razavi AC, Richardson LC, Coronado F, Vesper HW, Lyle A, Bhatia HS, Tsimikas S, Quyyumi AA, Vaccarino V, Eapen DJ, Isiadinso I, Mehta A, Yadalam AK, Osei J, Jacobson TA, Yao Z, Dzaye O, Martin SS, Nasir K, Shapiro MD, Blaha MJ, Whelton SP, Blumenthal RS, Sperling LS.
    JACC Adv. 2025 May 30;4(6 Pt 1):101826. doi: 10.1016/j.jacadv.2025.101826. Online ahead of print.

  50. Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II Trial
    Fröbert O, Stone GW, Larsen AI, Zhou Z, Kotinkaduwa LN, Engstrøm T, Kjøller-Hansen L, Maeng M, Matsumura M, Ben-Yehuda O, Bøtker HE, Persson J, Wiseth R, Jensen LO, Nordrehaug JE, Trovik T, Jensen U, Bleie Ø, James SK, Ali ZA, Omerovic E, Erlinge D, Maehara A.
    JACC Cardiovasc Interv. 2025 May 26;18(10):1217-1228. doi: 10.1016/j.jcin.2025.01.440. Epub 2025 Apr 23.

  51. Patient and Cardiologist Perspectives on the Treatment of Patients With Concomitant ASCVD and Obesity
    Taub P, Knight MG, McCarty D, Robar C, Traina A, Behnke L.
    J Patient Exp. 2025 May 20;12:23743735251342141. doi: 10.1177/23743735251342141. eCollection 2025.

  52. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
    Laffin LJ, Kopjar B, Melgaard C, Wolski K, Ibbitson J, Bhikam S, Weir MR, Ofili EO, Mehra R, Luther JM, Cohen DL, Sarraju A, Wilkinson MJ, Flack JM, Rodman D, Nissen SE; Advance-HTN Investigators.
    N Engl J Med. 2025 May 8;392(18):1813-1823. doi: 10.1056/NEJMoa2501440. Epub 2025 Apr 23.

  53. Enhancement of Statin Effects on Lipid Lowering and Reduction of Cardiovascular Risk Score by (-)-Epicatechin in Proof-of-Concept Pilot Study
    Ormiston CK, Pazargadi A, Rosander A, Ceballos G, Villarreal F, Taub PR.
    Clin Transl Sci. 2025 May;18(5):e70236. doi: 10.1111/cts.70236.

  54. Practice patterns and percutaneous coronary intervention outcomes: a comparison between Sweden and the US
    Sampath-Kumar R, Mohammad M, von Koch S, Reeves R, Al Khiami B, Ang L, Melendez A, Mahmud E, Ben-Yehuda O, Erlinge D.
    Eur Heart J Open. 2025 Apr 18;5(3):oeaf045. doi: 10.1093/ehjopen/oeaf045. eCollection 2025 May.

  55. Impact of Hispanic Ethnicity, Geography, and Insurance Status on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
    Sampath-Kumar R, Mahmud E, Palakodeti V, Ang L, Al Khiami B, Melendez A, Reeves R, Ben-Yehuda O.
    JACC Adv. 2025 May;4(5):101723. doi: 10.1016/j.jacadv.2025.101723. Epub 2025 Apr 26.

  56. Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA)
    Rikhi R, Haidar A, Bhatia HS, Beam K, McParland J, Kazibwe R, Chevli P, Schaich CL, Sanghavi M, Shapiro MD.
    Atherosclerosis. 2025 May;404:119179. doi: 10.1016/j.atherosclerosis.2025.119179. Epub 2025 Mar 27.

  57. Aortic Stenosis - When Valve Intervention Is Not Enough
    Ben-Yehuda O.
    N Engl J Med. 2025 Apr 10;392(14):1443-1444. doi: 10.1056/NEJMe2503345. Epub 2025 Mar 29.

  58. Role of Aspirin in Reducing Risk for Atherosclerotic Cardiovascular Disease in Individuals with Elevated Lipoprotein(a)
    Razavi AC, Bhatia HS.
    Curr Atheroscler Rep. 2025 Apr 8;27(1):49. doi: 10.1007/s11883-025-01296-w.

  59. Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS.
    Circulation. 2025 Apr;151(13):e865. doi: 10.1161/CIR.0000000000001328. Epub 2025 Mar 31.

  60. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Rao SV, O'Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS.
    Circulation. 2025 Apr;151(13):e771-e862. doi: 10.1161/CIR.0000000000001309. Epub 2025 Feb 27.

  61. Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD
    Van Mieghem NM, Elmariah S, Spitzer E, Pibarot P, Nazif TM, Bax JJ, Hahn RT, Popma A, Ben-Yehuda O, Kallel F, Redfors B, Chuang ML, Alu MC, Lindeboom W, Kolte D, Zahr FE, Kodali SK, Strote JA, Hermanides RS, Cohen DJ, Tijssen JGP, Leon MB.
    J Am Coll Cardiol. 2025 Mar 11;85(9):878-890. doi: 10.1016/j.jacc.2024.10.070. Epub 2024 Oct 28.

  62. Clinical Performance of an N-Terminal Pro-B-Type Natriuretic Peptide Assay in Acute Heart Failure Diagnosis
    Daniels LB, Ajongwen P, Christenson RH, Clark CL, Diercks DB, Fermann GJ, Mace SE, Mahler SA, Pang PS, Rafique Z, Runyon MS, Tauras J, deFilippi CR.
    J Appl Lab Med. 2025 Mar 3;10(2):325-338. doi: 10.1093/jalm/jfae107.

  63. Transcatheter Aortic Valve Replacement Sizing: Getting It Right
    Ben-Yehuda O, Reeves RR.
    Struct Heart. 2024 May 9;9(3):100302. doi: 10.1016/j.shj.2024.100302. eCollection 2025 Mar.

  64. Breast Arterial Calcification as a Cardiovascular Risk Factor: Time to "Bust" It Out
    Daniels LB, Itchhaporia D.
    JACC Adv. 2025 Mar;4(3):101638. doi: 10.1016/j.jacadv.2025.101638. Epub 2025 Feb 24.

  65. Treatment options to break the cycle of recurrent pericarditis
    Raisinghani AB, Luis SA.
    Curr Opin Cardiol. 2025 Mar 1;40(2):107-114. doi: 10.1097/HCO.0000000000001201. Epub 2025 Jan 10.

  66. Lipoprotein(a), high-sensitivity c-reactive protein, homocysteine and cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis
    Nomura SO, Bhatia HS, Garg PK, Karger AB, Guan W, Cao J, Shapiro MD, Tsai MY.
    Am J Prev Cardiol. 2024 Dec 11;21:100903. doi: 10.1016/j.ajpc.2024.100903. eCollection 2025 Mar.

  67. Coronary Artery Calcium Distribution and Cardiovascular Risk: MESA
    Allen TS, Reyes M, Kermanshahchi JM, Denenberg JO, Yeboah J, Allison MA, Criqui MH, Bhatia HS.
    JACC Cardiovasc Imaging. 2025 Mar;18(3):392-394. doi: 10.1016/j.jcmg.2024.10.005. Epub 2024 Dec 4.

  68. Calcium Scoring and Plaque Density: Room for Improvement
    Bhatia HS.
    JACC Cardiovasc Imaging. 2025 Mar;18(3):305-307. doi: 10.1016/j.jcmg.2024.09.004. Epub 2024 Nov 6.

  69. Characteristics and Outcomes of Patients With Cardiogenic Shock and Clinically Significant Valvular Heart Disease: From the Critical Care Cardiology Trials Network
    Carnicelli AP, Miller PE, Berg DD, Aliyev N, Alviar CL, Bohula EA, Chaudhry SP, Chonde M, Chow C, Cooper HA, Daniels LB, Fordyce CB, Ghafghazi S, Goldfarb MJ, Gorder KL, Hamilton MM, Keane RR, Kontos MC, Kusner JJ, Leibner E, Loriaux DB, Menon V, Nair RM, Newby LK, Oduah MT, Palazzolo MG, Patolia H, Pierce JB, Pierce MJ, Potter BJ, Proudfoot A, Roswel RO, Schnell G, Shaw J, Sidhu K, Sinha SS, Varshney AS, Katz JN, Diepen SV, Morrow DA.
    J Card Fail. 2025 Feb 17:S1071-9164(25)00058-2. doi: 10.1016/j.cardfail.2025.01.019. Online ahead of print.

  70. Red Meat Consumption and Hypertension: An Updated Review
    Allen TS, Najem M, Wood AC, Lee DJ, Pacheco LS, Daniels LB, Allison MA.
    Curr Cardiol Rep. 2025 Feb 10;27(1):50. doi: 10.1007/s11886-025-02201-2.

  71. Polygenic risk, aspirin, and primary prevention of coronary artery disease
    Yu C, Natarajan P, Patel AP, Bhatia HS, Khera AV, Neumann JT, Tsimikas S, Wolfe R, Nicholls SJ, Reid CM, Zoungas S, Tonkin AM, McNeil JJ, Lacaze P.
    Eur Heart J Cardiovasc Pharmacother. 2025 Feb 8;11(1):84-91. doi: 10.1093/ehjcvp/pvae085.

  72. Transcatheter Left Ventricular Reconstruction in Heart Failure Patients With Prior Anterior Myocardial Infarction: The Prospective ALIVE Trial
    Estep JD, Ben-Yehuda O, Wechsler AS, Puri R, Kao AC, Heimes JK, Pfeiffer MP, Boehmer JP, Ninios V, Zaman A, Stone GW.
    JACC Heart Fail. 2025 Feb;13(2):296-308. doi: 10.1016/j.jchf.2024.09.023. Epub 2025 Jan 8.

  73. The long-term vascular and myocardial outcomes in selected Kawasaki disease patients with regression of giant coronary artery aneurysms
    Kung SC, Miyata K, Colvert GM, Kahn AM, Daniels LB, Hoshino S, Dummer KB, Golding IF, Roberts S, Shimizu C, Tremoulet AH, McVeigh ER, Gordon JB, Burns JC.
    Cardiol Young. 2025 Feb;35(2):289-296. doi: 10.1017/S104795112403614X. Epub 2024 Nov 21.

  74. Insights and Opportunities from Multimarker Evaluation of Heart Failure: Lessons from BIOSTAT-HF
    Birs AS, Mazdeyasnan D, Daniels LB.
    Curr Heart Fail Rep. 2025 Jan 29;22(1):7. doi: 10.1007/s11897-024-00694-6.

  75. Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis
    Bhatia HS, Wandel S, Willeit P, Lesogor A, Bailey K, Ridker PM, Nestel P, Simes J, Tonkin A, Schwartz GG, Colhoun H, Wanner C, Tsimikas S.
    Circulation. 2025 Jan 28;151(4):312-321. doi: 10.1161/CIRCULATIONAHA.124.069556. Epub 2024 Nov 4.

  76. Correction: Smoking is associated with increased risk of cardiovascular events, disease severity, and mortality among patients hospitalized for SARS-CoV-2 infections
    Poudel R, Daniels LB, DeFilippis AP, Hamburg NM, Khan Y, Keith RJ, Kumar RS, Stokes AC, Robertson RM, Bhatnagar A.
    PLoS One. 2025 Jan 24;20(1):e0318361. doi: 10.1371/journal.pone.0318361. eCollection 2025.

  77. Patient Characteristics and Outcomes of Radial to Femoral Access-Site Crossover
    Sampath-Kumar R, Mahmud E, Korkmaz K, Ang L, Al Khiami B, Melendez A, Reeves R, Ben-Yehuda O.
    J Soc Cardiovasc Angiogr Interv. 2025 Jan 21;4(1):102450. doi: 10.1016/j.jscai.2024.102450. eCollection 2025 Jan.

  78. Complete Revascularization Wins in ST-Segment Elevation Myocardial Infarction, But Timing Remains Flexible
    Ben-Yehuda O, Mahmud E.
    J Am Coll Cardiol. 2025 Jan 7;85(1):39-41. doi: 10.1016/j.jacc.2024.10.078.

  79. Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients
    Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ.
    J Clin Lipidol. 2025 Jan-Feb;19(1):134-145. doi: 10.1016/j.jacl.2024.10.005. Epub 2024 Nov 13.

  80. Dietary patterns to promote cardiometabolic health
    Pagidipati NJ, Taub PR, Ostfeld RJ, Kirkpatrick CF.
    Nat Rev Cardiol. 2025 Jan;22(1):38-46. doi: 10.1038/s41569-024-01061-7. Epub 2024 Jul 17.

  81. Oxidized Phospholipids and Calcific Aortic Valvular Disease
    Bhatia HS, Dweck MR, Craig N, Capoulade R, Pibarot P, Trainor PJ, Whelton SP, Rikhi R, Lidani KCF, Post WS, Tsai MY, Criqui MH, Shapiro MD, Budoff MJ, DeFilippis AP, Thanassoulis G, Tsimikas S.
    J Am Coll Cardiol. 2024 Dec 17;84(25):2430-2441. doi: 10.1016/j.jacc.2024.08.070. Epub 2024 Nov 15.

  82. Major Bleeding and Mortality After Revascularization of Left Main Disease
    Giustino G, Sabik JF 3rd, Serruys PW, Puskas JD, Karmpaliotis D, Kandzari DE, Morice MC, Ragosta M 3rd, Zhang Z, Dressler O, Redfors B, Ben-Yehuda O, Sharma SK, Kappetein AP, Stone GW.
    J Am Coll Cardiol. 2024 Dec 10;84(24):2335-2346. doi: 10.1016/j.jacc.2024.07.065.

  83. Peak Procedural ACT Is Associated With All-Cause Mortality After Femoral Access PCI
    Sampath-Kumar R, Ben-Yehuda O, Al Khiami B, Ang L, Melendez A, Reeves R, Mahmud E.
    J Soc Cardiovasc Angiogr Interv. 2024 Sep 23;3(12):102387. doi: 10.1016/j.jscai.2024.102387. eCollection 2024 Dec.

  84. Association of Lipoprotein(a) With Major Adverse Cardiovascular Events Across hs-CRP: A Systematic Review and Meta-Analysis
    Alebna PL, Han CY, Ambrosio M, Kong G, Cyrus JW, Harley K, Kang L, Small AM, Chevli P, Bhatia H, Chew N, Salloum FN, Dixon DL, Abbate A, Natarajan P, Shapiro MD, Mehta A.
    JACC Adv. 2024 Nov 19;3(12):101409. doi: 10.1016/j.jacadv.2024.101409. eCollection 2024 Dec.

  85. Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans
    Banerjee S, Garimella PS, Hong KN, Bullen AL, Daniels LB, Wettersten N.
    Int J Cardiol Heart Vasc. 2024 Nov 16;55:101557. doi: 10.1016/j.ijcha.2024.101557. eCollection 2024 Dec.

  86. Representation of women and racial minorities in SGLT2 inhibitors and heart failure clinical trials
    Gupta R, Umeh C, Mohta T, Vaidya A, Wolfson A, Nattiv J, Bhatia H, Kaur G, Dhawan R, Darji P, Eghreriniovo B, Sanwo E, Hotwani P, Mahdavian P, Kumar S, Tiwari B.
    Int J Cardiol Heart Vasc. 2024 Oct 20;55:101539. doi: 10.1016/j.ijcha.2024.101539. eCollection 2024 Dec.

  87. Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay
    Wilkinson MJ, Shapiro MD.
    Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2396-2406. doi: 10.1161/ATVBAHA.124.319983. Epub 2024 Oct 31.

  88. Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis
    Cao J, Guan W, Nomura SO, Bhatia HS, Garg PK, Tsai MY.
    Lipids Health Dis. 2024 Nov 14;23(1):375. doi: 10.1186/s12944-024-02363-y.

  89. Lipoprotein(a): Don't forget about secondary prevention
    Bhatia HS, Boccara F.
    Eur J Prev Cardiol. 2024 Nov 11;31(15):1888-1889. doi: 10.1093/eurjpc/zwae276.

  90. Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality
    Allen TS, Bui QM, Petersen GM, Mantey R, Wang J, Nerlekar N, Eghtedari M, Daniels LB.
    JACC Adv. 2024 Sep 27;3(11):101283. doi: 10.1016/j.jacadv.2024.101283. eCollection 2024 Nov.

  91. Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action
    Maron DJ, Budoff MJ, Sky JC, Bommer WJ, Epstein SD, Fisher DA, Stock EO, Taylor AJ, Wong ND, DeMaria AN.
    JACC Adv. 2024 Sep 24;3(11):101287. doi: 10.1016/j.jacadv.2024.101287. eCollection 2024 Nov.

  92. Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial
    Manoogian ENC, Wilkinson MJ, O'Neal M, Laing K, Nguyen J, Van D, Rosander A, Pazargadi A, Gutierrez NR, Fleischer JG, Golshan S, Panda S, Taub PR.
    Ann Intern Med. 2024 Nov;177(11):1462-1470. doi: 10.7326/M24-0859. Epub 2024 Oct 1.

  93. Strategies for management of patients with elevated lipoprotein(a)
    Ellberg CC, Bhatia HS.
    Curr Opin Lipidol. 2024 Oct 1;35(5):234-240. doi: 10.1097/MOL.0000000000000950. Epub 2024 Aug 14.

  94. Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction
    de Waha S, Patel MR, Thiele H, Udelson JE, Granger CB, Ben-Yehuda O, Kotinkaduwa L, Redfors B, Eitel I, Selker HP, Maehara A, Stone GW.
    J Am Heart Assoc. 2024 Sep 17;13(18):e034748. doi: 10.1161/JAHA.123.034748. Epub 2024 Sep 9.

  95. Guideline-directed medical therapy prescribing patterns and in-hospital outcomes among heart failure patients during COVID-19
    Srivastava PK, Klomhaus AM, Rafique A, Desai PS, Daniels LB, Yancy CW, Yang EH, Fonarow GC, Parikh RV.
    Am Heart J Plus. 2024 Aug 2;45:100440. doi: 10.1016/j.ahjo.2024.100440. eCollection 2024 Sep.

  96. Continuum of Preshock to Classic Cardiogenic Shock in the Critical Care Cardiology Trials Network Registry
    Patel SM, Berg DD, Bohula EA, Baird-Zars VM, Park JG, Barnett CF, Daniels LB, Fordyce CB, Ghafghazi S, Goldfarb MJ, Gorder K, Kwon Y, Leibner E, Menon V, Potter BJ, Prasad R, Solomon MA, Teuteberg JJ, Thompson AD, Zakaria S, Katz JN, van Diepen S, Morrow DA.
    JACC Heart Fail. 2024 Sep;12(9):1625-1635. doi: 10.1016/j.jchf.2024.06.009. Epub 2024 Jul 31.

  97. Predictors of outcomes after PCI with incomplete revascularization: Impact of CTO and LAD vessel
    Kuno T, Weisz G, Généreux P, Claessen BE, Shechter M, Alexander KP, James SK, Ohman EM, Dressler O, Mehran R, Ben-Yehuda O, Stone GW.
    Catheter Cardiovasc Interv. 2024 Sep;104(3):483-491. doi: 10.1002/ccd.31142. Epub 2024 Jul 15.

  98. Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry
    Daniels LB, Phreaner N, Berg DD, Bohula EA, Chaudhry SP, Fordyce CB, Goldfarb MJ, Katz JN, Kenigsberg BB, Lawler PR, Martillo Correa MA, Papolos AI, Roswell RO, Sinha SS, van Diepen S, Park JG, Morrow DA; Critical Care Cardiology Trials Network Investigators.
    Circ Cardiovasc Qual Outcomes. 2024 Aug;17(8):e010614. doi: 10.1161/CIRCOUTCOMES.123.010614. Epub 2024 Jun 20.

  99. Repeat Mitral Valve Interventions After Transcatheter Edge-to-Edge Repair: The COAPT Trial
    Shahim B, Cohen DJ, Asch FM, Bax J, George I, Rück A, Ben-Yehuda O, Kar S, Lim DS, Saxon JT, Zhou Z, Lindenfeld J, Abraham WT, Mack MJ, Stone GW.
    Am J Cardiol. 2024 Jul 15;223:7-14. doi: 10.1016/j.amjcard.2024.05.025. Epub 2024 May 23.

  100. The Impact of Obesity on Cardiorespiratory Fitness and Weight Changes in a Cardiac Rehabilitation Program
    Mittal N, Sonners C, Raphelson J, Sykes A, Roberts E, Swiatkiewicz I, Taub PR, Malhotra A, Schmickl CN.
    J Cardiopulm Rehabil Prev. 2024 Jul 1;44(4):E9-E11. doi: 10.1097/HCR.0000000000000870. Epub 2024 Jun 6.

  101. Control of diabetes mellitus and the risk of neointimal hyperplasia after percutaneous coronary intervention: Post-hoc analysis from the BLADE-PCI trial
    Jonas M, Genereux P, Maehara A, Ben-Yehuda O, Stone GW, Chernin G.
    Atherosclerosis. 2024 Jul;394:117264. doi: 10.1016/j.atherosclerosis.2023.117264. Epub 2023 Sep 3.

  102. Feasibility and Cardiometabolic Effects of Time-Restricted Eating in Patients with Metabolic Syndrome
    Świątkiewicz I, Nuszkiewicz J, Wróblewska J, Nartowicz M, Sokołowski K, Sutkowy P, Rajewski P, Buczkowski K, Chudzińska M, Manoogian ENC, Taub PR, Woźniak A.
    Nutrients. 2024 Jun 7;16(12):1802. doi: 10.3390/nu16121802.

  103. E pluribus unum-: Understanding Our Diversity and Disparities in Lp(a) Screening
    Patel J, Bhatia HS, Spitz JA.
    JACC Adv. 2024 May 1;3(6):100939. doi: 10.1016/j.jacadv.2024.100939. eCollection 2024 Jun.

  104. Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)
    Razavi AC, Richardson LC, Coronado F, Dzaye O, Bhatia HS, Mehta A, Quyyumi AA, Vaccarino V, Budoff MJ, Nasir K, Tsimikas S, Whelton SP, Blaha MJ, Blumenthal RS, Sperling LS.
    Am J Prev Cardiol. 2024 Apr 27;18:100674. doi: 10.1016/j.ajpc.2024.100674. eCollection 2024 Jun.

  105. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management
    Patel N, Mittal N, Wilkinson MJ, Taub PR.
    Am J Prev Cardiol. 2024 Apr 5;18:100666. doi: 10.1016/j.ajpc.2024.100666. eCollection 2024 Jun.

  106. Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography
    Nurmohamed NS, van Rosendael AR, Danad I, Ngo-Metzger Q, Taub PR, Ray KK, Figtree G, Bonaca MP, Hsia J, Rodriguez F, Sandhu AT, Nieman K, Earls JP, Hoffmann U, Bax JJ, Min JK, Maron DJ, Bhatt DL.
    Eur Heart J. 2024 May 27;45(20):1783-1800. doi: 10.1093/eurheartj/ehae190.

  107. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
    Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM.
    J Clin Lipidol. 2024 May-Jun;18(3):e308-e319. doi: 10.1016/j.jacl.2024.03.001. Epub 2024 Apr 1.

  108. Hypertension, microvascular obstruction and infarct size in patients with STEMI undergoing PCI: Pooled analysis from 7 cardiac magnetic resonance imaging studies
    Mehdipoor G, Redfors B, Chen S, Gkargkoulas F, Zhang Z, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, de Waha-Thiele S, Thiele H, Stone GW.
    Am Heart J. 2024 May;271:148-155. doi: 10.1016/j.ahj.2024.02.023. Epub 2024 Mar 1.

  109. Variation in risk-adjusted cardiac intensive care unit (CICU) length of stay and the association with in-hospital mortality: An analysis from the Critical Care Cardiology Trials Network (CCCTN) registry
    Koerber DM, Katz JN, Bohula E, Park JG, Dodson MW, Gerber DA, Hillerson D, Liu S, Pierce MJ, Prasad R, Rose SW, Sanchez PA, Shaw J, Wang J, Jentzer JC, Kristin Newby L, Daniels LB, Morrow DA, van Diepen S.
    Am Heart J. 2024 May;271:28-37. doi: 10.1016/j.ahj.2024.02.010. Epub 2024 Feb 16.

  110. Lipoprotein(a), platelet function and cardiovascular disease
    Bhatia HS, Becker RC, Leibundgut G, Patel M, Lacaze P, Tonkin A, Narula J, Tsimikas S.
    Nat Rev Cardiol. 2024 May;21(5):299-311. doi: 10.1038/s41569-023-00947-2. Epub 2023 Nov 8.

  111. Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy
    Blaha MJ, Bhatia HS.
    J Am Coll Cardiol. 2024 Apr 23;83(16):1540-1542. doi: 10.1016/j.jacc.2024.03.370. Epub 2024 Mar 25.

  112. Prognostic performance of the IABP-SHOCK II Risk Score among cardiogenic shock subtypes in the critical care cardiology trials network registry
    Alviar CL, Li BK, Keller NM, Bohula-May E, Barnett C, Berg DD, Burke JA, Chaudhry SP, Daniels LB, DeFilippis AP, Gerber D, Horowitz J, Jentzer JC, Katrapati P, Keeley E, Lawler PR, Park JG, Sinha SS, Snell J, Solomon MA, Teuteberg J, Katz JN, van Diepen S, Morrow DA; CCCTN Investigators.
    Am Heart J. 2024 Apr;270:1-12. doi: 10.1016/j.ahj.2023.12.018. Epub 2024 Jan 6.

  113. Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran
    Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR.
    J Am Heart Assoc. 2024 Mar 19;13(6):e032031. doi: 10.1161/JAHA.123.032031. Epub 2024 Mar 8.

  114. Impact of Incomplete Revascularization After PCI in Left Main Disease: The EXCEL Trial
    Ali ZA, Garcia JJ, Karimi Galougahi K, Horst J, Gallo A, Shin D, Ben-Yehuda O, Chen S, Redfors B, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW.
    Circ Cardiovasc Interv. 2024 Mar;17(3):e013192. doi: 10.1161/CIRCINTERVENTIONS.123.013192. Epub 2024 Mar 19.

  115. Atherothrombotic and thrombolytic biomarkers in incident stroke and atrial fibrillation-related stroke: The Multi-Ethnic Study of Atherosclerosis (MESA)
    Lidani KCF, Trainor PJ, Bhatia HS, Nasir K, Blaha MJ, Tsai MY, Gottesman RF, Post WS, Thanassoulis G, Tsimikas S, Heckbert SR, DeFilippis AP.
    Atherosclerosis. 2024 Mar;390:117451. doi: 10.1016/j.atherosclerosis.2024.117451. Epub 2024 Jan 10.

  116. Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi-Ethnic Study of Atherosclerosis
    Bhatia HS, Trainor P, Carlisle S, Tsai MY, Criqui MH, DeFilippis A, Tsimikas S.
    J Am Heart Assoc. 2024 Feb 6;13(3):e033562. doi: 10.1161/JAHA.123.033562. Epub 2024 Jan 31.

  117. Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery: JACC State-of-the-Art Review
    Milam AJ, Ogunniyi MO, Faloye AO, Castellanos LR, Verdiner RE, Stewart JW 2nd, Chukumerije M, Okoh AK, Bradley S, Roswell RO, Douglass PL, Oyetunji SO, Iribarne A, Furr-Holden D, Ramakrishna H, Hayes SN.
    J Am Coll Cardiol. 2024 Jan 30;83(4):530-545. doi: 10.1016/j.jacc.2023.11.015.

  118. Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk
    Kornowski R, Konigstein M, Jonas M, Assali A, Vaknin-Assa H, Segev A, Danenberg H, Halabi M, Roguin A, Kerner A, Lev E, Karamasis GV, Johnson TW, Anderson R, Blaxill J, Jadhav S, Hoole S, Witberg G, Issever MO, Ben-Yehuda O, Baumbach A.
    J Am Heart Assoc. 2024 Jan 16;13(2):e029051. doi: 10.1161/JAHA.122.029051. Epub 2024 Jan 12.

  119. Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry
    Donnelly S, Barnett CF, Bohula EA, Chaudhry SP, Chonde MD, Cooper HA, Daniels LB, Dodson MW, Gerber D, Goldfarb MJ, Guo J, Kontos MC, Liu S, Luk AC, Menon V, O'Brien CG, Papolos AI, Pisani BA, Potter BJ, Prasad R, Schnell G, Shah KS, Sridharan L, So DYF, Teuteberg JJ, Tymchak WJ, Zakaria S, Katz JN, Morrow DA, van Diepen S.
    Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e010092. doi: 10.1161/CIRCOUTCOMES.123.010092. Epub 2024 Jan 5.

  120. Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies
    Garg PK, Bhatia HS, Allen TS, Grainger T, Pouncey AL, Dichek D, Virmani R, Golledge J, Allison MA, Powell JT.
    Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):24-47. doi: 10.1161/ATVBAHA.123.320138. Epub 2023 Nov 21.

  121. Performance of a novel artificial intelligence software developed to derive coronary fractional flow reserve values from diagnostic angiograms
    Ben-Assa E, Abu Salman A, Cafri C, Roguin A, Hellou E, Koifman E, Feld Y, Lev E, Sheinman G, Harari E, Abu Dogosh A, Beyar R, Garcia-Garcia HM, Davies J, Ben-Yehuda O.
    Coron Artery Dis. 2023 Dec 1;34(8):533-541. doi: 10.1097/MCA.0000000000001305. Epub 2023 Oct 18.

  122. Reference Values for Inward Displacement in the Normal Left Ventricle: A Novel Method of Regional Left Ventricular Function Assessment
    Hegeman RRMJJ, McManus S, Tóth A, Ladeiras-Lopes R, Kitslaar P, Bui V, Dukker K, Harb SC, Swaans MJ, Ben-Yehuda O, Klein P, Puri R.
    J Cardiovasc Dev Dis. 2023 Nov 24;10(12):474. doi: 10.3390/jcdd10120474.

  123. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
    Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, Lurz P, Lindman BR, Topilsky Y, Baron SJ, Chadderdon S, Khalique OK, Tang GHL, Taramasso M, Grayburn PA, Badano L, Leipsic J, Lindenfeld J, Windecker S, Vemulapalli S, Redfors B, Alu MC, Cohen DJ, Rodés-Cabau J, Ailawadi G, Mack M, Ben-Yehuda O, Leon MB, Hausleiter J.
    Eur Heart J. 2023 Nov 14;44(43):4508-4532. doi: 10.1093/eurheartj/ehad653.

  124. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
    Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, Lurz P, Lindman BR, Topilsky Y, Baron SJ, Chadderdon S, Khalique OK, Tang GHL, Taramasso M, Grayburn PA, Badano L, Leipsic J, Lindenfeld J, Windecker S, Vemulapalli S, Redfors B, Alu MC, Cohen DJ, Rodés-Cabau J, Ailawadi G, Mack M, Ben-Yehuda O, Leon MB, Hausleiter J; TVARC Steering Committee.
    Ann Thorac Surg. 2023 Nov;116(5):908-932. doi: 10.1016/j.athoracsur.2023.09.018. Epub 2023 Oct 4.

  125. Time-Restricted Eating: A Novel Dietary Strategy for Cardiac Rehabilitation
    Small S, Iglesies-Grau J, Gariepy C, Wilkinson M, Taub P, Kirkham A.
    Can J Cardiol. 2023 Nov;39(11S):S384-S394. doi: 10.1016/j.cjca.2023.09.017. Epub 2023 Sep 20.

  126. Prognostic significance of haemodynamic parameters in patients with cardiogenic shock
    Berg DD, Kaur G, Bohula EA, Baird-Zars VM, Alviar CL, Barnett CF, Barsness GW, Burke JA, Chaudhry SP, Chonde M, Cooper HA, Daniels LB, Dodson MW, Gerber DA, Ghafghazi S, Gidwani UK, Goldfarb MJ, Guo J, Hillerson D, Kenigsberg BB, Kochar A, Kontos MC, Kwon Y, Lopes MS, Loriaux DB, Miller PE, O'Brien CG, Papolos AI, Patel SM, Pisani BA, Potter BJ, Prasad R, Rowsell RO, Shah KS, Sinha SS, Smith TD, Solomon MA, Teuteberg JJ, Thompson AD, Zakaria S, Katz JN, van Diepen S, Morrow DA.
    Eur Heart J Acute Cardiovasc Care. 2023 Oct 25;12(10):651-660. doi: 10.1093/ehjacc/zuad095.

  127. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
    Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, Lurz P, Lindman BR, Topilsky Y, Baron SJ, Chadderdon S, Khalique OK, Tang GHL, Taramasso M, Grayburn PA, Badano L, Leipsic J, Lindenfeld J, Windecker S, Vemulapalli S, Redfors B, Alu MC, Cohen DJ, Rodés-Cabau J, Ailawadi G, Mack M, Ben-Yehuda O, Leon MB, Hausleiter J; TVARC Steering Committee.
    J Am Coll Cardiol. 2023 Oct 24;82(17):1711-1735. doi: 10.1016/j.jacc.2023.08.008. Epub 2023 Oct 4.

  128. Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes
    Ma GS, Chiou TT, Wilkinson MJ.
    Curr Cardiol Rep. 2023 Oct;25(10):1175-1187. doi: 10.1007/s11886-023-01937-z. Epub 2023 Aug 26.

  129. Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial
    Udelson JE, Kelsey MD, Nanna MG, Fordyce CB, Yow E, Clare RM, Mark DB, Patel MR, Rogers C, Curzen N, Pontone G, Maurovich-Horvat P, De Bruyne B, Greenwood JP, Marinescu V, Leipsic J, Stone GW, Ben-Yehuda O, Berry C, Hogan SE, Redfors B, Ali ZA, Byrne RA, Kramer CM, Yeh RW, Martinez B, Mullen S, Huey W, Anstrom KJ, Al-Khalidi HR, Chiswell K, Vemulapalli S, Douglas PS; PRECISE Investigators.
    JAMA Cardiol. 2023 Oct 1;8(10):915-924. doi: 10.1001/jamacardio.2023.2614.

  130. Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial
    Douglas PS, Nanna MG, Kelsey MD, Yow E, Mark DB, Patel MR, Rogers C, Udelson JE, Fordyce CB, Curzen N, Pontone G, Maurovich-Horvat P, De Bruyne B, Greenwood JP, Marinescu V, Leipsic J, Stone GW, Ben-Yehuda O, Berry C, Hogan SE, Redfors B, Ali ZA, Byrne RA, Kramer CM, Yeh RW, Martinez B, Mullen S, Huey W, Anstrom KJ, Al-Khalidi HR, Vemulapalli S; PRECISE Investigators.
    JAMA Cardiol. 2023 Oct 1;8(10):904-914. doi: 10.1001/jamacardio.2023.2595.

  131. Aspirin and lipoprotein(a) in primary prevention
    Bhatia HS.
    Curr Opin Lipidol. 2023 Oct 1;34(5):214-220. doi: 10.1097/MOL.0000000000000891. Epub 2023 Jul 31.

  132. Predictors of Myocardial Ischemia in Patients with Kawasaki Disease: Insights from Patient-Specific Simulations of Coronary Hemodynamics
    Menon K, Seo J, Fukazawa R, Ogawa S, Kahn AM, Burns JC, Marsden AL.
    J Cardiovasc Transl Res. 2023 Oct;16(5):1099-1109. doi: 10.1007/s12265-023-10374-w. Epub 2023 Mar 20.

  133. Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States
    Bhatia HS, Hurst S, Desai P, Zhu W, Yeang C.
    J Am Heart Assoc. 2023 Sep 19;12(18):e031255. doi: 10.1161/JAHA.123.031255. Epub 2023 Sep 13.

  134. Inferior vena cava diameter and risk of acute decompensated heart failure rehospitalisations
    Sampath-Kumar R, Ben-Yehuda O.
    Open Heart. 2023 Sep;10(2):e002331. doi: 10.1136/openhrt-2023-002331.

  135. Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosis
    Bhatia HS, Rikhi R, Allen TS, Yeang C, Guan W, Garg PK, Tsai MY, Criqui MH, Shapiro MD, Tsimikas S.
    Atherosclerosis. 2023 Sep;381:117217. doi: 10.1016/j.atherosclerosis.2023.117217. Epub 2023 Aug 9.

  136. Percutaneous coronary intervention with ridaforolimus-eluting stents in long lesions: the BIONICS 38 mm prospective trial
    Jonas M, Ben-Yehuda O, Banai S, Segev A, Danenberg H, Assali A, Tuvali O, Haberman D, Chernin G.
    Coron Artery Dis. 2023 Sep 1;34(6):410-414. doi: 10.1097/MCA.0000000000001264. Epub 2023 Jul 4.

  137. High density lipoprotein: When to rethink too much of a good thing
    Dastmalchi LN, German CA, Taub PR.
    Am J Prev Cardiol. 2023 Jun 22;15:100511. doi: 10.1016/j.ajpc.2023.100511. eCollection 2023 Sep.

  138. Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived
    Tsimikas S, Bhatia HS, Erlinge D.
    J Clin Lipidol. 2023 Sep-Oct;17(5):567-570. doi: 10.1016/j.jacl.2023.06.005. Epub 2023 Jul 1.

  139. Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials
    Shapiro MD, Taub PR, Louie MJ, Lei L, Ballantyne CM.
    Atherosclerosis. 2023 Aug;378:117182. doi: 10.1016/j.atherosclerosis.2023.06.973. Epub 2023 Jun 29.

  140. Combination Therapy With Lower Statin Dose and the Race to LDL-C Goal: A Clear Winner?
    Ben-Yehuda O.
    J Am Coll Cardiol. 2023 Aug 1;82(5):411-413. doi: 10.1016/j.jacc.2023.06.003.

  141. Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit
    Kadosh BS, Berg DD, Bohula EA, Park JG, Baird-Zars VM, Alviar C, Alzate J, Barnett CF, Barsness GW, Burke J, Chaudhry SP, Daniels LB, DeFilippis A, Delicce A, Fordyce CB, Ghafghazi S, Gidwani U, Goldfarb M, Katz JN, Keeley EC, Kenigsberg B, Kontos MC, Lawler PR, Leibner E, Menon V, Metkus TS, Miller PE, O'Brien CG, Papolos AI, Prasad R, Shah KS, Sinha SS, Snell RJ, So D, Solomon MA, Ternus BW, Teuteberg JJ, Toole J, van Diepen S, Morrow DA, Roswell RO.
    JACC Heart Fail. 2023 Aug;11(8 Pt 1):903-914. doi: 10.1016/j.jchf.2023.04.007. Epub 2023 Jun 14.

  142. 5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique
    Stone GW, Kereiakes DJ, Gori T, Metzger DC, Stein B, Erickson M, Torzewski J, Kabour A, Piegari G, Cavendish J, Bertolet B, Stockelman KA, West NEJ, Ben-Yehuda O, Choi JW, Marx SO, Spertus JA, Ellis SG; ABSORB IV Investigators.
    J Am Coll Cardiol. 2023 Jul 18;82(3):183-195. doi: 10.1016/j.jacc.2023.05.003. Epub 2023 May 17.

  143. Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
    Albosta MS, Grant JK, Taub P, Blumenthal RS, Martin SS, Michos ED.
    Vasc Health Risk Manag. 2023 Jul 6;19:421-431. doi: 10.2147/VHRM.S338424. eCollection 2023.

  144. Lipoprotein(a) and coronary artery calcium in comparison with other lipid biomarkers: The multi-ethnic study of atherosclerosis
    Jackson CL, Garg PK, Guan W, Tsai MY, Criqui MH, Tsimikas S, Bhatia HS.
    J Clin Lipidol. 2023 Jul-Aug;17(4):538-548. doi: 10.1016/j.jacl.2023.06.002. Epub 2023 Jun 17.

  145. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
    Wilkinson MJ, Lepor NE, Michos ED.
    J Am Heart Assoc. 2023 Jun 6;12(11):e028892. doi: 10.1161/JAHA.122.028892. Epub 2023 Jun 1.

  146. Managing Patients With Moderate Aortic Stenosis
    Stassen J, Ewe SH, Pio SM, Pibarot P, Redfors B, Leipsic J, Genereux P, Van Mieghem NM, Kuneman JH, Makkar R, Hahn RT, Playford D, Marsan NA, Delgado V, Ben-Yehuda O, Leon MB, Bax JJ.
    JACC Cardiovasc Imaging. 2023 Jun;16(6):837-855. doi: 10.1016/j.jcmg.2022.12.013. Epub 2023 Feb 8.

  147. The Impact of Underlying Obstructive Sleep Apnea Treatment on Exercise Capacity in Patients With Pulmonary Hypertension Undergoing a Cardiac Rehabilitation Program
    Sykes AV, Sonners C, Schmickl CN, Raphelson J, Swiatkiewicz I, Roberts E, Feldman E, Malhotra A, Taub PR.
    J Cardiopulm Rehabil Prev. 2023 May 1;43(3):186-191. doi: 10.1097/HCR.0000000000000745. Epub 2022 Dec 14.

  148. Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
    Velarde G, Bravo-Jaimes K, Brandt EJ, Wang D, Douglass P, Castellanos LR, Rodriguez F, Palaniappan L, Ibebuogu U, Bond R, Ferdinand K, Lundberg G, Thamman R, Vijayaraghavan K, Watson K.
    J Am Heart Assoc. 2023 Apr 18;12(8):e025271. doi: 10.1161/JAHA.122.025271. Epub 2023 Mar 21.

  149. Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
    Bhatt AS, Daniels LB, de Lemos J, Goodrich E, Bohula EA, Morrow DA; AHA COVID-19 CVD Registry Investigators.
    Am Heart J. 2023 Apr;258:149-156. doi: 10.1016/j.ahj.2022.12.014. Epub 2023 Jan 18.

  150. Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery disease
    Wilkinson MJ, Xu I, Vasudevan RS, You H, Xu R, Taub PR.
    Am J Prev Cardiol. 2023 Feb 13;13:100473. doi: 10.1016/j.ajpc.2023.100473. eCollection 2023 Mar.

  151. Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry
    Sammour YM, Spertus JA, Kennedy K, Morrow DA, Daniels LB, Jones P, Alger H, Stevens L, Shah A, Goel SS, de Lemos JA, Hayek SS, Sutton NR, Kleiman NS.
    Am Heart J Plus. 2023 Mar;27:100265. doi: 10.1016/j.ahjo.2023.100265. Epub 2023 Feb 3.

  152. Small dense low-density lipoprotein cholesterol compared to other lipoprotein biomarkers for predicting coronary heart disease among individuals with normal fasting glucose: The Multi-Ethnic Study of Atherosclerosis
    Nomura SO, Karger AB, Garg P, Cao J, Bhatia H, Duran EK, Duprez D, Guan W, Tsai MY.
    Am J Prev Cardiol. 2022 Dec 9;13:100436. doi: 10.1016/j.ajpc.2022.100436. eCollection 2023 Mar.

  153. Retinal vein occlusion is associated with stroke independent of underlying cardiovascular disease
    Bakhoum CY, Madala S, Long CK, Adabifirouzjaei F, Freeman WR, Goldbaum MH, DeMaria AN, Bakhoum MF.
    Eye (Lond). 2023 Mar;37(4):764-767. doi: 10.1038/s41433-022-02038-x. Epub 2022 Apr 11.

  154. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial
    Shahim B, Cohen DJ, Ben-Yehuda O, Redfors B, Kar S, Lim DS, Arnold SV, Li Y, Lindenfeld J, Abraham WT, Mack MJ, Stone GW.
    J Am Heart Assoc. 2023 Feb 21;12(4):e028444. doi: 10.1161/JAHA.122.028444. Epub 2023 Feb 8.

  155. Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
    deFilippi CR, Tran H, Gattani R, Daniels LB, Shah P, Ilkhanoff L, Christenson R, Lima JA, Seliger S.
    Front Cardiovasc Med. 2023 Feb 9;10:1104715. doi: 10.3389/fcvm.2023.1104715. eCollection 2023.

  156. Describing Sepsis as a Risk Factor for Cardiovascular Disease
    Wardi G, Pearce A, DeMaria A, Malhotra A.
    J Am Heart Assoc. 2023 Feb 7;12(3):e028882. doi: 10.1161/JAHA.122.028882. Epub 2023 Feb 1.

  157. Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II
    Gyldenkerne C, Maeng M, Kjøller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Erik Bøtker H, Engstrøm T, Matsumura M, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Rosen HC, Stone GW, Erlinge D.
    Circulation. 2023 Feb 7;147(6):469-481. doi: 10.1161/CIRCULATIONAHA.122.061983. Epub 2022 Dec 16.

  158. Coronary Artery Calcium Density and Cardiovascular Events by Volume Level: The MESA
    Bhatia HS, McClelland RL, Denenberg J, Budoff MJ, Allison MA, Criqui MH.
    Circ Cardiovasc Imaging. 2023 Feb;16(2):e014788. doi: 10.1161/CIRCIMAGING.122.014788. Epub 2023 Feb 21.

  159. What Is the Clinical Utility of Cardiac Troponins in Heart Failure? Are They Modifiable Beyond Their Prognostic Value?
    Agdashian D, Daniels LB.
    Curr Heart Fail Rep. 2023 Feb;20(1):33-43. doi: 10.1007/s11897-023-00588-z. Epub 2023 Jan 31.

  160. Lipoprotein(a) and Aortic Valve Calcification: The Multi-Ethnic Study of Atherosclerosis
    Bhatia HS, Zheng KH, Garg PK, Guan W, Whelton SP, Budoff MJ, Tsai MY.
    JACC Cardiovasc Imaging. 2023 Feb;16(2):258-260. doi: 10.1016/j.jcmg.2022.09.007. Epub 2022 Nov 16.

  161. Association of Lp(a) (Lipoprotein[a]) and Hypertension in Primary Prevention of Cardiovascular Disease: The MESA
    Rikhi R, Bhatia HS, Schaich CL, Ashburn N, Tsai MY, Michos ED, Chevli PA, Herrington DM, Tsimikas S, Shapiro MD.
    Hypertension. 2023 Feb;80(2):352-360. doi: 10.1161/HYPERTENSIONAHA.122.20189. Epub 2022 Dec 13.

  162. On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES
    Shahim B, Redfors B, Stuckey TD, Liu M, Zhou Z, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Srdanovic I, Madhavan MV, Mazzaferri EL Jr, Mehran R, Ben-Yehuda O, Kirtane AJ, Stone GW.
    J Am Heart Assoc. 2023 Jan 3;12(1):e026482. doi: 10.1161/JAHA.122.026482. Epub 2022 Dec 24.

  163. Etiology of pulmonary hypertension in multiple myeloma: A case series and literature review
    Desmarais T, Yang J, Narezkina A, Fernandes T.
    Respir Med. 2023 Jan;206:107071. doi: 10.1016/j.rmed.2022.107071. Epub 2022 Dec 7.

  164. Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic
    Chiou TT, Tomasi K, Taub PR, Wilkinson MJ.
    J Clin Lipidol. 2023 Jan-Feb;17(1):73-77. doi: 10.1016/j.jacl.2022.10.009. Epub 2022 Nov 1.